Search Results - "Eshelman, F"

Pharmacokinetics of ranitidine following oral administration with ascending doses and with multiple-fixed doses by Garg, D C, Eshelman, F N, Weidler, D J

“…The aim of these studies was to further delineate pharmacokinetic characteristics of ranitidine, a new histamine H2-receptor antagonist. In one study,…”
Get more information

Pharmacokinetics of ranitidine in patients with renal failure by Garg, D C, Baltodano, N, Jallad, N S, Perez, G, Oster, J R, Eshelman, F N, Weidler, D J

“…The pharmacokinetics of ranitidine were studied in ten patients with renal failure (creatinine clearance, 6-54 mL/min) after intravenous (IV) (50 mg) and oral…”
Get more information

Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease by Blumer, J L, Rothstein, F C, Kaplan, B S, Yamashita, T S, Eshelman, F N, Myers, C M, Reed, M D

“…The pharmacokinetics and pharmacodynamics of ranitidine were evaluated during three methods of administration in 12 children ranging in age from 3.5 to 16…”
Get more information

Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis by SICA, D. A, COMSTOCK, T, HARFORD, A, ESHELMAN, F

“…Ranitidine kinetics in renal failure were evaluated in six patients undergoing continuous ambulatory peritoneal dialysis (CAPD). On separate occasions each…”
Get full text

Letter: Communication among pharmacists by Eshelman, F

Get more information

Pharmacokinetics of Amoxicillin and Ampicillin: Crossover Study of the Effect of Food by Eshelman, F N, Spyker, D A

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepam by Abernethy, D R, Greenblatt, D J, Eshelman, F N, Shader, R I

“…Potential interactions of ranitidine with antipyrine, diazepam, and lorazepam were evaluated. Ten healthy male subjects were injected intravenously with…”
Get more information

The effects of several weeks of ethanol consumption on ethanol kinetics in normal men and women by Holtzman, J L, Gebhard, R L, Eckfeldt, J H, Mottonen, L R, Finley, D K, Eshelman, F N

“…We examined in normal men and women the effects of chronic ethanol consumption and the coadministration of cimetidine and ranitidine on the kinetics of…”
Get more information

A multicenter study of ranitidine treatment of duodenal ulcers in the United States by Hirschowitz, B I, Berenson, M M, Berkowitz, J M, Bright-Asare, P, DeLuca, Jr, V A, Eshelman, F N, Font, R G, Griffin, Jr, J W, Kozarek, R A, McCray, R S

“…Treatment of duodenal ulcer with the histamine H2-receptor antagonist, ranitidine, was assessed in a double-blind, randomized, multicenter trial in which…”
Get more information

Effect of packaging on patient compliance with an antihypertensive medication by Eshelman, F N, Fitzloff, J

Get more information

The influence of H2-receptor antagonists on steady-state concentrations of propranolol and 4-hydroxypropranolol by Donn, K H, Powell, J R, Rogers, J F, Eshelman, F N

“…Twelve healthy male volunteers were treated with 1200 mg/day cimetidine, 300 mg/day ranitidine, or no H2-receptor antagonist (control) for seven days in a…”
Get more information

Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone by Sirgo, M A, Rocci, Jr, M L, Ferguson, R K, Eshelman, F N, Vlasses, P H

“…Prednisone is a glucocorticoid that must be converted in vivo to prednisolone for pharmacologic activity. We examined the effects of the H2-receptor…”
Get more information

Ranitidine disposition and systemic availability in hepatic cirrhosis by Smith, I L, Ziemniak, J A, Bernhard, H, Eshelman, F N, Martin, L E, Schentag, J J

“…Single-dose ranitidine kinetics were studied in 10 patients with cirrhosis as proved by liver biopsy. All were clinically stable. After an overnight fast,…”
Get more information

Ranitidine bioavailability and disposition kinetics in patients undergoing chronic hemodialysis by Comstock, T J, Sica, D A, Harford, A, Eshelman, F

“…The absorption and disposition of single-dose intravenous (i.v.) and oral ranitidine were evaluated in 6 patients undergoing chronic hemodialysis. Ranitidine…”
Get more information

Ranitidine bioavailability and kinetics in normal male subjects by Garg, D C, Weidler, D J, Eshelman, F N

“…Ranitidine is a potent histamine H2-receptor blocker that inhibits histamine- and pentagastrin-induced gastric acid secretion. After doses of 100 mg both…”
Get more information

Quantitative urine analysis for measuring compliance by Fitzloff, J, Eshelman, F

Get more information

"Placebo" responsiveness of peptic ulcers by Eshelman, F, Sanzari, N, DeFelice, S

Get more information

Pharmaceutical services for the primary care health team by Eshelman, F N, Campagna, K D

Get more information

Protocol design for recent duodenal ulcer maintenance trials by Eshelman, F N, Holland, C E

“…The long-term efficacy and safety of ranitidine for the prevention of duodenal ulcer recurrence were studied in two sets of double-blind, randomized,…”
Get more information

Clinical comparison of cimetidine and ranitidine by Brater, D C, Peters, M N, Eshelman, F N, Richardson, C T

“…Ranitidine is a histamine H2-receptor antagonist that differs structurally from cimetidine. We assessed its kinetics, potency, and duration of effect in…”
Get more information